Breathlessness ‐ early effect VAS 0‐10. Scale from: 0 to 10. · exacerbations of COPD
1 finding from 1 review
Proportion of people with hospital admissions (from the emergency room) · acute exacerbations of chronic obstructive pulmonary disease
Intravenous magnesium sulfate + standard care may leads to lower proportion of people with hospital admissions (from the emergency… compared with placebo + standard care (low certainty).
1 finding from 1 review
Proportion of people requiring non‐invasive ventilation · acute exacerbations of chronic obstructive pulmonary disease
It is very uncertain whether intravenous magnesium sulfate + standard care changes proportion of people requiring non‐invasive ventilation compared with placebo + standard care (very low certainty).
1 finding from 1 review
Proportion of people with serious adverse events · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Length of hospital stay · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Change in oxygen saturation (SaO2) · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Change in dyspnoea score · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Lung function: FEV1 mL (change from baseline) · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Hospital admissions · children with acute asthma in the emergency department
MgSO4 may leads to lower hospital admissions compared with placebo (low certainty).
1 finding from 1 review
ED treatment duration (minutes) · children with acute asthma in the emergency department
1 finding from 1 review
Return to ED within 48 hours · children with acute asthma in the emergency department
MgSO4 showed no clear difference in return to ED within 48 hours compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · children with acute asthma in the emergency department
1 finding from 1 review
Intervention not reported
Hospital admissions · adults with acute asthma
The intervention leads to lower hospital admissions (high certainty).
1 finding from 1 review
Intervention not reported
Intensive care unit (ICU) admissions · adults with acute asthma
The intervention showed no clear difference in intensive care unit (ICU) admissions (low certainty).
1 finding from 1 review
Intervention not reported
Length of hospital stay (days) · adults with acute asthma
1 finding from 1 review
Intervention not reported
ED treatment duration (minutes) · adults with acute asthma
1 finding from 1 review
Intervention not reported
FEV1 (% predicted) · adults with acute asthma
1 finding from 1 review
Intervention not reported
PEF (L/min) · adults with acute asthma
1 finding from 1 review
Intervention not reported
Respiratory rate (breaths/min) · adults with acute asthma
1 finding from 1 review
PEF (L/min) · patients with adults with acute asthma
Aminophylline showed no clear difference in PEF (L/min) ‐ at 60 min compared with placebo (low certainty).
1 finding from 1 review